Healthcare Industry News: benzoyl peroxide
News Release - July 6, 2006
SkinMedica Appoints Theodore Ebel Vice President of Corporate Development
SAN DIEGO--(HSMN NewsFeed)--July 5, 2006--SkinMedica, Inc. announced today that Theodore Ebel has joined the Company as Vice President, Corporate Development. In this position Mr. Ebel will be responsible for strategic planning and business development activities for the Company. He will be actively seeking the acquisition of marketed and development-stage dermatology products. He will also lead the partnering activities to acquire or license patented topical drug delivery technologies to support SkinMedica's ongoing initiatives to develop and market innovative products for the treatment of dermatological conditions."Ted is a very strong addition to SkinMedica's senior management team," said Rex Bright, President & Chief Executive Officer. "Under Ted's leadership, Corporate Development will continue our active acquisition and licensing activities. These activities will augment our in-house product development efforts."
Mr. Ebel's experience includes management roles with Arthur D. Little Company, Amgen, MP.3 and CancerVax, Inc. He is a graduate of Duke University, and received his MBA Degree from the Wharton School at the University of Pennsylvania.
About SkinMedica
SkinMedica is a privately held specialty pharmaceutical company marketing both prescription and cosmeceutical dermatology products. SkinMedica's EpiQuin® Micro (4% Hydroquinone) treats melasma and postinflammatory hyperpigmentation, VANIQA® (eflornithine hydrochloride) Cream, 13.9%, is the only FDA-approved prescription product for the treatment of unwanted facial hair in women, and NeoBenz® Micro, which contains a patented gradual-release formulation of benzoyl peroxide, treats acne. The company's full line of cosmeceutical products, which is sold through physicians, includes TNS Recovery Complex® with NouriCel-MD® to help improve the health and appearance of aging skin. SkinMedica is based in Carlsbad, California. For more information, visit: www.skinmedica.com.
EpiQuin®Micro, NeoBenz® Micro, NouriCel-MD®, SkinMedica®, TNS Recovery Complex® and VANIQA® are trademarks of SkinMedica, Inc.
Source: SkinMedica
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
